IncFact
Company Profiles: Revenue, Growth, Competition

Biological Product Manufacturing Industry

NAICS: 325414

For additional companies see the Pharmaceutical & Medicine Manufacturing Industry

Contents

.Biological Product Manufacturing Market Share: Largest Companies in the Biological Product Manufacturing Industry

Company HeadquartersRevenue ($ MM)
OXFORD BIOMEDICA SOLUTIONSBedford, MA100 
MG BIOLOGICSAmes, IA39 
GREEN MOUNTAIN ANTIBODIESBurlington, VT34 
MOLECULAR TOXICOLOGY INC. D/B/A MOLTOXBoone, NC13 
BIOCOLLECTIONS WORLDWIDEMiami, FL12 
DIRECT BIOLOGICSSaint Louis, MO11 
VXBIOSCIENCESBerkeley, CA9 
LUCINA BIOSCIENCESAurora, CO9 
BIOGEMS INTERNATIONALOak Park, CA7 
CHAMELEON BIOSCIENCESAlbany, CA7 
CYAGEN BIOMODELSSanta Clara, CA4 
ATHENS RESEARCH & TECHNOLOGYAthens, GA3 
KARMA BIOTECHNOLOGIESLos Angeles, CA2 
LESCARDENNew York, NY1 


See exact company revenues in this list


This is a list of the largest companies active in the Biological Product Manufacturing industry. This differs from market share in the following example: One business with revenues of $100 million generates 10% of its business from the Biological Product Manufacturing industry. A second firm, with revenues of $20 million, generates all of its business from this industry. In our list, we show the businesses having revenues of $100 million and $20 million, respectively. However, the market share would compare the $10 million in industry-specific revenue to the $20 million: the second company has twice the market share even though it is "smaller" in size.


.Growth: Fastest Growing Biological Product Manufacturing Companies

A list of competitors in the Biological Product Manufacturing industry that are rapidly expanding. Businesses may grow organically or through acquisition. Typically, small or midsized companies are in "growth" mode and can expand more rapidly. However, large businesses may have the strategy and financial capabilities to scale rapidly. Businesses that employ a "roll-up" strategy make multiple acquisitions of smaller businesses to form a single large corporation that controls a greater market share than its competitors and benefits from economies of scale.

View List


View Full List


.Small Business Financing

Small businesses that have received financing may expand soon. Financing may be required for capital-intensive investments, such as real estate or equipment purchases. Biological Product Manufacturing businesses may use the financing to cover startup expenses or the costs of hiring new employees. Loans differ from equity investments in the level of risk that is expected: loans frequently have collateral either directly or implicitly through the business or the owners that ensure repayment. Equity investment has the possibility for much greater returns, but offers no guarantee the principle will be repaid. Convertible securities combine the two concepts, but is used by private-equity firms rather than main street startups.

View List


. Venture Funding

These Biological Product Manufacturing companies are actively raising capital from venture capital firms, private equity, or other investors. Businesses with venture funding generally have higher growth prospects, either through bringing new concepts to market, using innovative business practices, or savvy management.

View List